Stay updated with breaking news from Gamida Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Faster immune reconstitution and decreased rate of post-transplant viral infection in patients transplanted with Omisirge versus umbilical cord blood
11.07.2023 - Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the publication in press of a prospective sub-study of the Phase 3 clinical trial for Omisirge (omidubicel-onlv), the company’s ... Seite 1
/PRNewswire/ -- Stand Up To Cancer® (SU2C) today announced that Julian Adams, Ph.D., a longtime oncology researcher and retired pharmaceutical industry chief...
Gamida Cell Ltd. (NASDAQ:GMDA – Free Report) was the target of a significant growth in short interest in the month of June. As of June 15th, there was short interest totalling 4,270,000 shares, a growth of 34.3% from the May 31st total of 3,180,000 shares. Based on an average daily volume of 5,350,000 shares, the […]
Gamida Cell Ltd. (NASDAQ:GMDA – Free Report) was the recipient of a large increase in short interest in June. As of June 15th, there was short interest totalling 4,270,000 shares, an increase of 34.3% from the May 31st total of 3,180,000 shares. Based on an average daily trading volume, of 5,350,000 shares, the days-to-cover ratio […]